Exploring the therapeutic implications of natural compounds modulating apoptosis in vascular dementia
Guangcheng Zhong1, Xinyue Wang2,3, Qian Zhang1
1Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Insights
Vascular dementia (VaD) involves brain cell death (apoptosis). Natural compounds show promise in protecting brain cells, offering potential new treatments for VaD.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Vascular dementia (VaD) is a common form of dementia linked to cerebrovascular disease, causing memory and executive function deficits.
- Current treatments for VaD are limited due to its complex development, highlighting the need for novel therapeutic strategies.
- Apoptosis, or programmed cell death, plays a significant role in VaD pathogenesis, making it a key target for intervention.
Purpose of the Study:
- To explore the molecular mechanisms of apoptosis in relation to VaD.
- To review the neuroprotective effects of natural compounds on VaD by modulating apoptosis.
- To provide a reference for developing new VaD pharmaceuticals.
Main Methods:
- Systematic review of existing research on apoptosis and VaD.
- Analysis of molecular pathways involved in apoptosis relevant to VaD.
- Evaluation of studies on natural compounds with potential therapeutic effects on VaD.
Main Results:
- Evidence suggests apoptosis significantly contributes to VaD onset and progression.
- Numerous natural compounds have demonstrated neuroprotective potential by regulating apoptosis in VaD models.
- Understanding apoptosis mechanisms is crucial for identifying effective VaD treatments.
Conclusions:
- Natural compounds targeting apoptosis represent a promising avenue for VaD treatment development.
- Further rigorous clinical trials are necessary to confirm the efficacy and safety of these compounds for VaD.
- This review serves as a foundation for future research into natural product-based VaD therapies.
Abstract:
Vascular dementia (VaD) is a prevalent form of dementia stemming from cerebrovascular disease, manifesting in memory impairment and executive dysfunction, thereby imposing a substantial societal burden. Unfortunately, no drugs have been approved for the treatment of VaD due to its intricate pathogenesis, and the development of innovative and efficacious medications is urgently needed. Apoptosis, a programmed cell death process crucial for eliminating damaged or unwanted cells within an organism, assumes pivotal roles in embryonic development and tissue homeostasis maintenance. An increasing body of evidence indicates that apoptosis may significantly influence the onset and progression of VaD, and numerous natural compounds have demonstrated significant therapeutic potential. Here, we discuss the molecular mechanisms underlying apoptosis and its correlation with VaD. We also provide a crucial reference for developing innovative pharmaceuticals by systematically reviewing the latest research progress concerning the neuroprotective effects of natural compounds on VaD by regulating apoptosis. Further high-quality clinical studies are imperative to firmly ascertain these natural compounds' clinical efficacy and safety profiles in the treatment of VaD.
More Related Videos
10:36In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption
Published on: June 20, 2017
08:23Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line
Published on: August 9, 2014
Related Concept Videos
Alzheimer's Disease: Treatment
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Drugs Affecting Neurotransmitter Synthesis
The Intrinsic Apoptotic Pathway
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
